Sagimet Biosciences (SGMT) Cash & Current Investments (2023 - 2024)
Historic Cash & Current Investments for Sagimet Biosciences (SGMT) over the last 2 years, with Q3 2024 value amounting to $152.5 million.
- Sagimet Biosciences' Cash & Current Investments rose 4972.8% to $152.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $152.5 million, marking a year-over-year increase of 4972.8%. This contributed to the annual value of $94.9 million for FY2023, which is N/A changed from last year.
- Latest data reveals that Sagimet Biosciences reported Cash & Current Investments of $152.5 million as of Q3 2024, which was up 4972.8% from $166.4 million recorded in Q2 2024.
- In the past 5 years, Sagimet Biosciences' Cash & Current Investments ranged from a high of $193.7 million in Q1 2024 and a low of $18.5 million during Q2 2023